The effects of 1,25-dihydroxyvitamin D3 on colon cancer cells depend on RhoA-ROCK-p38MAPK-MSK signaling

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 355-361

  Ordóñez Morán, Paloma ^a   Álvarez Díaz, Silvia ^a   Valle, Noelia ^a   Larriba, María Jesús ^a   Bonilla, Félix ^b   Muñoz, Alberto ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Colon cancer; Cystatin D; Gene regulation; MSK; RhoA; Vitamin D

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CALCITRIOL; CYCLIN D1; CYSTATIN D; CYSTEINE PROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE; RHO ASSOCIATED COILED KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VASOPRESSIN; VINCULIN; CST5 PROTEIN, HUMAN; CYSTATIN; MEMBRANE PROTEIN; MITOGEN AND STRESS-ACTIVATED PROTEIN KINASE 1; OCCLUDIN; OCLN PROTEIN, HUMAN; RHO KINASE; RHOA PROTEIN, HUMAN; S6 KINASE;

ARTICLE; CANCER CELL; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIOID CELL; HUMAN; HUMAN TISSUE; INTRACELLULAR SIGNALING; PROTEIN FUNCTION; CELL MEMBRANE; CELL PROLIFERATION; COLON TUMOR; CONFOCAL MICROSCOPY; GENE EXPRESSION REGULATION; METABOLISM; PROCEDURES; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TUMOR CELL LINE;

CALCITRIOL; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN D1; CYSTATINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS; OCCLUDIN;

EID: 77954761401     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.02.031     Document Type: Article

References (18)

1. Agoston E.S., Hatcher M.A., Kensler T.W., Posner G.H. Vitamin D analogs as anti-carcinogenic agents. Anticancer Agents Med. Chem. 2006, 6:53-71.
2. Campbell M.J., Adorini L. The vitamin D receptor as a therapeutic target. Expert Opin. Ther. Targets 2006, 10:735-748.
3. Deeb K.K., Trump D.L., Johnson C.S. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer 2007, 7:684-700.
4. Grant W.B., Garland C.F. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr. Cancer 2004, 48:115-123.
5. Wu K., Feskanich D., Fuchs C.S., Willett W.C., Hollis B.W., Giovannucci E.L. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J. Natl. Cancer Inst. 2007, 99:1120-1129.
6. Gorham E.D., Garland C.F., Garland F.C., Grant W.B., Mohr S.B., Lipkin M., Newmark H.L., Giovannucci E., Wei M., Holick M.F. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am. J. Prev. Med. 2007, 32:210-216.
7. 3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J. Cell Biol. 2001, 154:369-387.
8. 3 in human colon cancer cells. Cancer Res. 2003, 63:7799-7806.
9. Ordóñez-Morán P., Larriba M.J., Pálmer H.G., Valero R.A., Barbáchano A., Duñach M., de Herreros A.G., Villalobos C., Berciano M.T., Lafarga M., Muñoz A. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J. Cell Biol. 2008, 183:697-710.
10. Álvarez-Díaz S., Valle N., García J.M., Peña C., Freije J.M., Quesada V., Astudillo A., Bonilla F., López-Otín C., Muñoz A. Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells. J. Clin. Invest. 2009, 119:2343-2358.
11. Freije J.P., Balbin M., Abrahamson M., Velasco G., Dalboge H., Grubb A., López-Otín C. Human cystatin D. cDNA cloning, characterization of the Escherichia coli expressed inhibitor, and identification of the native protein in saliva. J. Biol. Chem. 1993, 268:15737-15744.
12. Pendás-Franco N., García J.M., Peña C., Valle N., Pálmer H.G., Heinaniemi M., Carlberg C., Jiménez B., Bonilla F., Muñoz A., González-Sancho J.M. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3. Oncogene 2008, 27:4467-4477.
13. 3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol. Endocrinol. 2002, 16:1243-1256.
14. Carlberg C., Seuter S. A genomic perspective on vitamin D signaling. Anticancer Res. 2009, 29:3485-3493.
15. Ordóñez-Morán P., Muñoz A. Nuclear receptors: genomic and non-genomic effects converge. Cell Cycle 2009, 8:1675-1680.
16. Gocek E., Kielbinski M., Marcinkowska E. Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation. FEBS Lett. 2007, 581:1751-1757.
17. Charrasse S., Comunale F., Grumbach Y., Poulat F., Blangy A., Gauthier-Rouviere C. RhoA GTPase regulates M-cadherin activity and myoblast fusion. Mol. Biol. Cell 2006, 17:749-759.
18. Valastyan S., Reinhardt F., Benaich N., Calogrias D., Szasz A.M., Wang Z.C., Brock J.E., Richardson A.L., Weinberg R.A. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137:1032-1046.